期刊文献+

齐拉西酮合并舍曲林治疗精神分裂症阴性症状的疗效和不良反应 被引量:13

Efficacy and adverse reactions of ziprasidone combined with sertraline in the treatment of negative symptoms of schizophrenia
原文传递
导出
摘要 目的探讨齐拉西酮联合舍曲林治疗精神分裂症阴性症状的临床疗效。方法将娄底市中心医院2011年1月至2012年1月收治的114例精神分裂症阴性症状患者随机分为两组,其中对照组单纯采用齐拉西酮,观察组采取齐拉西酮联合舍曲林治疗,比较两组临床治疗效果及不良反应发生情况。结果观察组总有效率为85.96%,明显高于对照组的61.40%(P<0.05);两组治疗后PANSS总分均较治疗前明显减少,且观察组减少更为显著(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论齐拉西酮联合舍曲林可明显缓解精神分裂症患者的阴性症状,且不良反应少,依从性好,值得临床推广和应用。 Objective To investigate the efficacy of ziprasidone combined with sertraline on negative symptoms of schizophre- nia. Methods The patients with negative symptoms of schizophrenia treated in Loudi central hospital from January 2011 to 2012 were randomly divided into two groups, the patients in control group were treated with ziprasidone, while the patients in observa- tion group were given ziprasidone combined with sertraline, the clinical efficacy and adverse events were compared between the two groups. Results The total effective rate of the observation group was 85.96%, which was significantly higher than that of the control group(64.40% ), P 〈0. 05 ; The total scores of PANSS in the two groups after treatment significantly reduced than before, and the observation group decreased more significantly ( P 〈 0. 05 ) ; There was no significant difference in the incidence of adverse reactions between the two groups (P 〉 0. 05 ). Conclusion Ziprasidone combined with sertraline can significantly al- leviate the negative symptoms of schizophrenia, and it has few adverse reactions, has good compliance, and it is worth to be pro- moted and applied in clinics.
作者 谢红武
出处 《临床医学》 CAS 2013年第12期20-21,共2页 Clinical Medicine
关键词 齐拉西酮 舍曲林 精神分裂症 阴性症状 Ziprasidone Sertraline Schizophrenia Negative symptoms
  • 相关文献

参考文献9

二级参考文献50

共引文献73

同被引文献87

  • 1徐裕,余利霞,王忠良,毛福荣.舍曲林联合喹硫平治疗精神分裂症阴性症状疗效观察[J].中国全科医学,2009,12(14):1272-1273. 被引量:8
  • 2中华医学会精神科分会编.CCMD-3中国精神障碍分类与诊断标准.山东科学技术出版社,2001:31-91.
  • 3沈渔邨,主编.精神病学.第5版.北京:人民卫生出版社,2009,687-688.
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准[M].第3版.济南:山东科学技术出版社,2001:75-77.
  • 5Wu RR,Zhao JP, Liu ZN, et al. Effects of typical and atypical an tipsy chaotic on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia[J]. Psycho Harm Acology (Berl), 2012,186 (4) : 572-578.
  • 6Lin CH,Huang CL,Chang YC,et al. Clinical symptoms, mainly negative symptoms,mediate the influence of neu- rocognition and social cognition on functional outcome of schizophrenia[J]. Schizophr Res, 2013,146(3) : 231-237.
  • 7方政华,周剑,曾宪祥,等.齐拉西酮片治疗精神分裂症急性期不同给药方案的临床观察[J].延边医学,2014,21(18):52-53,54.
  • 8Emsley R,Berwaerts J,Eerdekens M,et al. Efficacy and safety of oral paliperidone extended-re/ease tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies[J]. Int Clin Psychopharmacol, 2012,23(6) : 343-356.
  • 9Kramer M,Simpson G,Maeiulis V,et al. One-year open- label safety and efficacy study of paliperidone extended- release tablets in patients with schizophrenia[J]. CNS Spec- tr, 2010, 15(8) :506-514.
  • 10Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antis choric drugs in patients with chronic schizophre- nia[J]. N Engt J Med,2012,353(10) : 1209-1223.

引证文献13

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部